Oramed Pharmaceuticals Market Cap 2011-2018 | ORMP
Oramed Pharmaceuticals market cap history and chart from 2011 to 2018. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of diluted shares outstanding. Oramed Pharmaceuticals market cap as of March 21, 2019 is $0.06B.
||Medical Products Manufacturing
Oramed Pharmaceuticals, Inc. is a pharmaceutical company operating as a developer of oral drug delivery systems. The Company is developing orally ingestible insulin capsules for the treatment of diabetes as well as delivery solutions for other drugs and vaccines. Oramed Pharmaceuticals, Inc. is headquartered in Jerusalem, Israel.